Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 35 min 47 sec ago

PediGuard(R) Device From SpineGuard is Recognized as “The Cutting-Edge and the New Gold Standard in Spine Care” by Becker’s Healthcare

Thu, 06/19/2014 - 12:27
PARIS & SAN FRANCISCO--(Healthcare Sales & Marketing Network)--SpineGuard (FR0011464452 – ALSGD), an innovative medical device company focused on improving spine surgery safety, announced today that its PediGuard device has been recognized by Becker’s Heal...
Devices, Orthopaedic, Neurosurgery
SpineGuard, PediGuard, pedicle screw, spine surgery

Takeda Announces Termination of Orteronel (TAK-700) Development for Prostate Cancer in Japan, U.S.A. and Europe

Thu, 06/19/2014 - 12:20
OSAKA, Japan--(Healthcare Sales & Marketing Network)--Takeda Pharmaceutical Company Limited (TSE:4502) announced today that it has voluntarily decided to end the development program for orteronel (TAK-700) for prostate cancer. The decision follows the resu...
Biopharmaceuticals, Oncology
Takeda Pharmaceutical, orteronel, prostate cancer

Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing

Wed, 06/18/2014 - 16:21
SARASOTA, Fla., June 18, 2014 -- (Healthcare Sales & Marketing Network) -- Lakewood-Amedex Inc., a leading developer of novel anti-infective pharmaceuticals, announced today that it has raised a total of $5.5 million, before fees and expenses, through a S...
Biopharmaceuticals, Venture Capital
Lakewood-Amedex, Bisphosphocin

Benvenue Medical Secures $64 Million Financing

Wed, 06/18/2014 - 12:38
Spine Company is Well-Poised for Rapid Growth in Vertebral Compression Fracture and Degenerative Disc Disease Markets SANTA CLARA, Calif., June 18, 2014 -- (Healthcare Sales & Marketing Network) -- Benvenue Medical, Inc., a developer of minimally invas...
Devices, Orthopaedic, Neurosurgery, Venture Capital
Benvenue Medical, Kiva VCF, Luna Interbody System, Blazer - C

Solace Therapeutics Receives Two FDA Clearances towards Providing Women an Office-Based Treatment for Stress Urinary Incontinence (SUI).

Wed, 06/18/2014 - 12:28
FRAMINGHAM, Mass. FRAMINGHAM, Mass.--(Healthcare Sales & Marketing Network)--Solace Therapeutics, Inc., today announced the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Guardian Urethral Sheath and Investig...
Devices, Urology, FDA
Solace Therapeutics, Guardian Urethral Sheath, Solace Bladder Control System

Miraculins Signs Letter of Intent for PreVu(R) Distribution in India With $4 Million USD in Minimum Sales Revenues Projected Over Term

Wed, 06/18/2014 - 12:17
WINNIPEG, MANITOBA--(Healthcare Sales & Marketing Network) - Miraculins Inc. (TSX VENTURE:MOM) ("Miraculins" or the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing diagnostic tests and risk ...
Diagnostics, Distribution
Miraculins, Citizen Doctor Pvt. Ltd, PreVu Non-invasive Skin Cholesterol

AngioDynamics Announces FDA Clearance for Celerity Tip Location System

Wed, 06/18/2014 - 12:10
ALBANY, N.Y., June 18, 2014 -- (Healthcare Sales & Marketing Network) -- AngioDynamics (ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the ...
Devices, FDA
AngioDynamics, Medcomp, Celerity tip, PICC

Oxford BioTherapeutics Appoints Dr Keith E Wilson as Chief Scientific Officer

Wed, 06/18/2014 - 12:05
OXFORD, England and SAN JOSE, California, June 18, 2014 -- (Healthcare Sales & Marketing Network) -- Oxford BioTherapeutics, an international biotechnology company focused on the development of innovative antibody-drug conjugates (ADCs) for the treatment ...
Biopharmaceuticals, Personnel
Oxford BioTherapeutics

Medtronic to Acquire Covidien for $42.9 billion in Cash and Stock

Tue, 06/17/2014 - 14:53
Creates a Medical Technology and Services Company with a Comprehensive Product Portfolio and Broad Global Reach that is Better Able to Improve Healthcare Outcomes Meaningfully Accelerates Medtronic`s Core Strategies of Therapy Innovation, Globalization ...
Devices, Mergers & Acquisitions
Medtronic, Covidien

Edwards Lifesciences Launching SAPIEN XT Valve In The U.S.

Tue, 06/17/2014 - 12:31
FDA Approval Includes High-Risk and Inoperable Indications, Transfemoral and Alternative Access Systems IRVINE, Calif., June 16, 2014 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (EW), the global leader in the science o...
Devices, Interventional Cardiology, Product Launch
Edwards Lifesciences, heart valve, SAPIEN XT, transcatheter aortic heart valve

Wright Medical Group, Inc. Announces Commercial Launch of INFINITY(R) Total Ankle System

Tue, 06/17/2014 - 12:13
Third Generation System Extends Leadership Position in Treating End-Stage Ankle Arthritis MEMPHIS, Tenn.--(Healthcare Sales & Marketing Network)--Wright Medical Group, Inc. (WMGI) today announced the full U.S. commercial launch of its INFINITY® Tota...
Devices, Orthopaedic, Product Launch
Wright Medical Group, INFINITY Total Ankle, Total Ankle

Regulus Appoints Paul C. Grint, M.D. as Chief Medical Officer

Mon, 06/16/2014 - 14:46
Recognized Industry Leader Brings Extensive Clinical and Product Development Expertise LA JOLLA, Calif., June 16, 2014 -- (Healthcare Sales & Marketing Network) -- Regulus Therapeutics Inc. (RGLS), a biopharmaceutical company leading the discovery and ...
Biopharmaceuticals, Personnel
Regulus Therapeutics, microRNA

Titan Medical Inc. Announces Completion of Key Milestone in the Development of Its SPORT(TM) Surgical System

Mon, 06/16/2014 - 14:38
TORONTO, ONTARIO--(Healthcare Sales & Marketing Network) - Titan Medical Inc. (the "Company") (TSX VENTURE:TMD)(TITXF) announced today that it successfully completed animal tissue studies on May 30, 2014, performing a full cholecystectomy (gallbl...
Devices, Surgery
Titan Medical, SPORT Surgical System, robotic surgery

Hill-Rom Announces Definitive Agreement To Acquire TRUMPF Medical

Mon, 06/16/2014 - 13:43
Combination Will Enhance Product Portfolio to Create Integrated Operating Room Solutions Provider Diversifies Revenue Stream and Expands Global Footprint Immediately Accretive To Adjusted EPS Company to Host Conference Call Today CHICAGO, June ...
Devices, Mergers & Acquisitions
Hill-Rom Holdings, TRUMPF Medical

Aastrom Announces Strategic Plan for Recently Acquired Cell Therapy and Regenerative Medicine Business

Mon, 06/16/2014 - 13:37
Manufacturing of MACI in Denmark to be discontinued Sales of MACI in Europe, representing 1% of revenues in 2014, temporarily ceased U.S. action plan implemented to optimize R&D, manufacturing and commercial operations Measures expected to enable ...
Regenerative Medicine
Aastrom Biosciences, Sanofi, Epicel

Sunshine Heart Appoints Brian Brown as Senior Vice President of Operations and Technology

Mon, 06/16/2014 - 13:28
EDEN PRAIRIE, Minn., June 16, 2014 -- (Healthcare Sales & Marketing Network) -- Sunshine Heart, Inc. (SSH) today announced the appointment of Brian Brown to the position of Senior Vice President of Operations and Technology. In this capacity, Mr. Brown wil...
Devices, Cardiology, Personnel
Sunshine Heart, C-Pulse Heart Assist

Agena Bioscience Announces FDA 510(k) Premarket Clearance of the IMPACT Dx(TM) Factor V Leiden and Factor II Genotyping Test on the IMPACT Dx(TM) System

Mon, 06/16/2014 - 13:20
IMPACT Dx™ Combined Function System Will Also Be Available in the European Union SAN DIEGO, June 16, 2014 -- (Healthcare Sales & Marketing Network) -- Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., was notifi...
Diagnostics, FDA
Agena Bioscience, Sequenom, IMPACT Dx, Factor V Leiden

Varian Medical Systems to Equip Prime Healthcare Services Hospitals with Varian Technology for Image-Guided Radiotherapy and Radiosurgery

Fri, 06/13/2014 - 12:57
Prime Healthcare acquires four TrueBeam™ systems as a step toward upgrading and standardizing cancer treatment services across its healthcare system PALO ALTO, Calif., June 13, 2014 -- (Healthcare Sales & Marketing Network) -- Varian Medical Systems (V...
Devices, Oncology
Varian Medical Systems, radiotherapy, radiosurgery, TrueBeam

Ligand Partner GSK Announces Results of Phase 3 PETIT2 Study of Eltrombopag (Promacta(TM)/Revolade(TM)) in Pediatric Patients with Chronic Immune Thrombocytopenia

Fri, 06/13/2014 - 12:48
SAN DIEGO--(Healthcare Sales & Marketing Network)--Ligand Pharmaceuticals Incorporated (LGND) announces that its partner, GlaxoSmithKline (GSK) plc, presented the results from the Phase 3 PETIT2 study evaluating the efficacy of eltrombopag vs. placebo in p...
Biopharmaceuticals
Ligand Pharmaceuticals, GlaxoSmithKline, Eltrombopag, Promacta, Revolade

EntreMed Stockholders Approve Name Change To CASI Pharmaceuticals

Fri, 06/13/2014 - 12:42
Common stock to begin trading under "CASI" on June 16, 2014 ROCKVILLE, Md., June 13, 2014 -- (Healthcare Sales & Marketing Network) -- EntreMed, Inc. (ENMD), a clinical-stage biopharmaceutical company developing therapeutics for the treatment...
Biopharmaceuticals
EntreMed, CASI Pharmaceuticals

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong